AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,418,000 | -32.8% | 8,817,000 | -34.3% | 0.01% | -37.5% |
| Q3 2019 | $11,035,000 | +11.2% | 13,417,000 | +8.2% | 0.01% | +33.3% |
| Q2 2019 | $9,924,000 | +12.4% | 12,400,000 | +22.2% | 0.01% | +20.0% |
| Q1 2019 | $8,830,000 | +206.7% | 10,150,000 | +222.2% | 0.01% | +150.0% |
| Q4 2018 | $2,879,000 | -68.8% | 3,150,000 | -64.2% | 0.00% | -33.3% |
| Q3 2018 | $9,235,000 | -19.9% | 8,800,000 | -22.1% | 0.00% | 0.0% |
| Q2 2018 | $11,535,000 | -23.1% | 11,300,000 | -22.4% | 0.00% | -57.1% |
| Q1 2018 | $15,000,000 | +32.9% | 14,564,000 | +10.7% | 0.01% | 0.0% |
| Q4 2017 | $11,286,000 | +1.1% | 13,154,000 | +14.6% | 0.01% | -12.5% |
| Q3 2017 | $11,159,000 | +104.2% | 11,476,000 | +101.3% | 0.01% | +100.0% |
| Q2 2017 | $5,466,000 | – | 5,702,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,800,000 | $9,006,000 | 7.74% |
| STEELHEAD PARTNERS LLC | 49,265,000 | $50,805,000 | 4.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,025,000 | $39,317,000 | 2.35% |
| CAMDEN ASSET MANAGEMENT L P /CA | 25,875,000 | $26,415,000 | 0.87% |
| Opera Trading Capital | 4,500,000 | $4,620,000 | 0.74% |
| Telemetry Investments, L.L.C. | 1,500,000 | $1,531,000 | 0.58% |
| SSI INVESTMENT MANAGEMENT LLC | 5,500,000 | $5,615,000 | 0.46% |
| AQR Arbitrage LLC | 32,975,000 | $33,746,000 | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,050,000 | $32,023,000 | 0.41% |
| City Financial Investment Co Ltd | 7,500,000 | $7,862,000 | 0.40% |